Genisphere Closes $2M in Funding

Genisphere_Logo-1Genisphere LLC, a Hatfield, PA-based provider of targeted drug delivery platform, closed $2m in funding.

Backers included existing investors Corporate Fuel Partners, a New York fund.

Led by Bob Getts, Chief Science Officer, Genisphere provides a DNA-based targeted drug delivery platform, called 3DNA®, to deliver a variety of therapeutics including small drugs, biologics, and nucleic acids and is also advancing its own lead oncology compounds based on the 3DNA platform.

The company intends to use the funds to accelerate platform development and advance its compounds.






Join the discussion